Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B McInnes

Showing results (291-300 of 537) with videos related to

Pageof 54
Sort By:
Journal of Dental Research|March 3, 2016
Mast Cells Contribute to Porphyromonas gingivalis-induced Bone LossJ Malcolm, O Millington, E Millhouse, et al.
Arthritis Research & Therapy|March 17, 2018
Efficacy and safety of secukinumab administration by autoinjector in patients with psoriatic arthritis: results from a randomized, placebo-controlled trial (FUTURE 3)Peter Nash, Philip J Mease, Iain B McInnes, et al.
Arthritis Care & Research|June 23, 2015
Maintenance of Clinical Efficacy and Radiographic Benefit Through Two Years of Ustekinumab Therapy in Patients With Active Psoriatic Arthritis: Results From a Randomized, Placebo-Controlled Phase III TrialArthur Kavanaugh, Lluís Puig, Alice B Gottlieb, et al.
Annals of the Rheumatic Diseases|July 19, 2008
Dissecting the contribution of innate and antigen-specific pathways to the breach of self-tolerance observed in a murine model of arthritisM B Nickdel, P Conigliaro, G Valesini, et al.
Clinical and Experimental Immunology|October 6, 2022
Stratification of alopecia areata reveals involvement of CD4 T cell populations and altered faecal microbiotaK A Bain, B Nichols, F Moffat, et al.
Rheumatology (Oxford, England)|October 20, 2021
A review of JAK-STAT signalling in the pathogenesis of spondyloarthritis and the role of JAK inhibitionIain B McInnes, Zoltán Szekanecz, Dennis McGonagle, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 24, 2018
Mavrilimumab, a Fully Human Granulocyte-Macrophage Colony-Stimulating Factor Receptor α Monoclonal Antibody: Long-Term Safety and Efficacy in Patients With Rheumatoid ArthritisGerd R Burmester, Iain B McInnes, Joel M Kremer, et al.
Annals of the Rheumatic Diseases|December 4, 2004
Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritisJ J Haringman, D M Gerlag, A H Zwinderman, et al.
RMD Open|November 19, 2021
Clinically relevant patient clusters identified by machine learning from the clinical development programme of secukinumab in psoriatic arthritisEffie Pournara, Matthias Kormaksson, Peter Nash, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 11, 2016
Brief Report: Proatherogenic Cytokine Microenvironment in the Aortic Adventitia of Patients With Rheumatoid ArthritisAmmad Ahmed, Ivana Hollan, Samuel A Curran, et al.
Pageof 54

Showing results (291-300 of 537) with videos related to

Sort By:
Pageof 54
Journal of Dental Research|March 3, 2016
Mast Cells Contribute to Porphyromonas gingivalis-induced Bone LossJ Malcolm, O Millington, E Millhouse, et al.
Arthritis Research & Therapy|March 17, 2018
Efficacy and safety of secukinumab administration by autoinjector in patients with psoriatic arthritis: results from a randomized, placebo-controlled trial (FUTURE 3)Peter Nash, Philip J Mease, Iain B McInnes, et al.
Arthritis Care & Research|June 23, 2015
Maintenance of Clinical Efficacy and Radiographic Benefit Through Two Years of Ustekinumab Therapy in Patients With Active Psoriatic Arthritis: Results From a Randomized, Placebo-Controlled Phase III TrialArthur Kavanaugh, Lluís Puig, Alice B Gottlieb, et al.
Annals of the Rheumatic Diseases|July 19, 2008
Dissecting the contribution of innate and antigen-specific pathways to the breach of self-tolerance observed in a murine model of arthritisM B Nickdel, P Conigliaro, G Valesini, et al.
Clinical and Experimental Immunology|October 6, 2022
Stratification of alopecia areata reveals involvement of CD4 T cell populations and altered faecal microbiotaK A Bain, B Nichols, F Moffat, et al.
Rheumatology (Oxford, England)|October 20, 2021
A review of JAK-STAT signalling in the pathogenesis of spondyloarthritis and the role of JAK inhibitionIain B McInnes, Zoltán Szekanecz, Dennis McGonagle, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 24, 2018
Mavrilimumab, a Fully Human Granulocyte-Macrophage Colony-Stimulating Factor Receptor α Monoclonal Antibody: Long-Term Safety and Efficacy in Patients With Rheumatoid ArthritisGerd R Burmester, Iain B McInnes, Joel M Kremer, et al.
Annals of the Rheumatic Diseases|December 4, 2004
Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritisJ J Haringman, D M Gerlag, A H Zwinderman, et al.
RMD Open|November 19, 2021
Clinically relevant patient clusters identified by machine learning from the clinical development programme of secukinumab in psoriatic arthritisEffie Pournara, Matthias Kormaksson, Peter Nash, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 11, 2016
Brief Report: Proatherogenic Cytokine Microenvironment in the Aortic Adventitia of Patients With Rheumatoid ArthritisAmmad Ahmed, Ivana Hollan, Samuel A Curran, et al.
Pageof 54